In this episode, host Shikha Jain, MD, speaks with Sean Bohen, MD, about how cancer therapies are changing how oncology can be discussed, shifting from clinical to industry work and more. • Welcome to another exciting episode of Oncology Overdrive :58 • About Bohen 1:04 • The interview 1:30 • Tell us about your journey. How did you become an oncologist, and how did you make the transition into working in the pharmaceutical industry? 1:51 • How did you end up at Olema Oncology after working with other pharmaceutical companies? What was your decision-making process to focus on the industry part of your career? 3:44 • Tell us more about what Olema Oncology does and what your role is there. 6:30 • What do you see coming down the pipeline for breast cancer research and innovation? … What do you think Olema will contribute to that space? 8:58 • Bohen and Jain on the ways in which new treatments have resulted in shifting conversations around cancer care and patient quality of life. 12:45 • If someone in fellowship is interested in working in industry, pharmaceuticals or scientific development, what are the most effective ways to get into this space? 18:21 • Jain and Bohen on changing the mindset and misconceptions around moving between clinical, academic and industry work within the field and after fellowship. 20:52 • What do you see happening in the oncology landscape twenty years from now? 25:46 • If someone could only listen to the last two minutes of this episode, what would you want them to take away? 29:19 • How to contact Bohen 30:54 • Thanks for listening 31:52 Sean Bohen, MD, is the President and CEO of Olema Oncology.

We'd love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Bohen can be reached at olema.com. Disclosures: Jain and Bohen report no relevant financial disclosures.